Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Agomab Therapeutics NV today announced the closing of its previously announced initial public offering of 12,500,000 American Depositary Shares (“ADSs”)
-
Agomab today announced the pricing of its initial public offering of 12,500,000 ADSs representing 12,500,000 of its common shares.
-
Agomab today announced the launch of its initial public offering of 12,500,000 ADSs pursuant to a registration statement filed with the SEC.